Plasma Protein Binding Characteristics of Neopanaxadiol in Rats by UPLC-MS/MS
GENG Cong1, WU Di2, L�� Hui-yi1, LI Yu-zhong1, SHI Wei-wei1, LIU Yong-er1, YIN Jian-yuan2*
1. The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China; 2. College of Pharmacy, Jilin University, Changchun 130021, China
Abstract��OBJECTIVE To develop an UPLC-MS/MS method for the determination of neopanaxadiol (NPD) in rat plasma sample, and to investigate plasma protein binding rate of NPD in rats. METHODS Under three different concentrations, equilibrium dialysis method was utilized to imitate the binding process between NPD and plasma protein. The concentration of NPD in and out of the dialysis membrane was determined by UPLC-MS/MS and the plasma protein binding rate of NPD were calculated. RESULTS Excellent linearity was found between 0.05-8 ��g��mL-1. Intra- and inter-day precision values (RSD) of QC samples were both below 15% and the extraction recoveries of NPD from biological matrices were better than 79.37%. The plasma protein binding rates of NPD were (86.55��4.50)%��(76.50��2.61)% and (78.25��1.32)% at low, middle and high concentrations, respectively. There was no significant difference among three concentrations. CONCLUSION These results indicate the high plasma protein binding rates of NPD in plasma in combination mode.
TAO L N, MENG Q, YIN J Y, et al. A new panaxadiol from the acid hydrolysate of Panax ginseng [J]. Chin Chem Lett, 2009, 20(6):687-689.
[2]
YIN J Y, MENG Q, TAO L N. A method for preparation of a new panaxadiol and derivatives and pharmaceutical application:China, ZL200710055693. 4 [P]. 2009-07-01.
[3]
WU L, LU C, DAI G L, et al. Determination of plasma protein binding rate of chlorogenic acid in Qingreyangxin granule [J]. Chin Pharmacol Bull(�й�ҩ��ѧͨ��), 2014, 30(9):1331-1332.
[4]
KONG A Y, WU H, LI J L, et al. Plasma protein binding characteristics of decapeptide in several species [J]. Chin Pharm J(�й�ҩѧ��־), 2016, 51(7):588-591.
[5]
GENG C, LIU J H, GUAN Q X, et al. Validated LC-ESI-MS/MS method for the quantitation of neopanaxadiol:a novel neuroprotective agent from Panax ginseng and its application to a pharmacokinetic study in rat plasma [J]. Chromatographia, 2013, 76(9-10):509-514.
[6]
RAO X Y, YIN S, ZHANG Y, et al. Determination of plasma protein binding rate of pulsatilla saponin D in several species [J]. Chin J Exp Tradit Med Form(�й�ʵ�鷽��ѧ��־), 2014, 20(8):114-117.
[7]
YE Y, HUANG Q J, LIU H G, et al. Plasma protein binding rate of dehydrocavidine determined by ultrafiltration [J]. J Chin Hosp Pharm(�й�ҽԺҩѧ��־), 2015, 35(1):12-15.
[8]
QIN L X, SI L Q, HUANG J G, et al. Determination of plasma protein binding of paroxetine hydrochloride in plasma and brain by HPLC-FLU [J]. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2016, 36(7):526-531.
[9]
GU Y, WANG G J, SUN J G, et al. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs [J]. Food Chem Toxicol, 2009, 47(9):2257-2268.
[10]
WU Y. Pharmacokinetic studies on 20(S)-protopanaxadiol and yijinsheng caps and domperidone [D]. Changchun:Jilin University, 2007.
[11]
ZHAO C F. Studies on the biological activity and pharmacokinetics and metabolism of pseudo-ginsenoside GQ [D]. Changchun:Jilin University, 2008.
[12]
LI L B, YU L H, WEI H L, et al. Determination of human and rat plasma protein binding rate of the novel anti-Parkinson's disease candidate drug FLZ [J]. Chin Pharm J(�й�ҩѧ��־), 2010, 45(21):1656-1660.
2017, Vol. 52 
